On 30 September 2024
The Board of Unichem Laboratories will meet on 30 September 2024 to consider and approve integration and consolidation of the generics formulations business in the US market of M/s. Bayshore Pharmaceuticals LLC (wholly owned subsidiary of Company's holding company, Ipca Laboratories) into Unichem Pharmaceuticals (USA) Inc. (company's wholly owned subsidiary) so as to consolidate all the Ipca Group's USA generics formulations business under one entity.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "Stock Market, Market, Crash, Funds, up, Stock, Lost, decline, statistic, Crisis, Capital, BSE, NSE")
 "Just a day ahead of the hurriedly called Vodafone Idea (Vi) meeting meant to soothe the nerves of investors amid the company's sliding stock price and a negative narrative around it, the telco announced a $3.6-billion (Rs 30,000 crore) deal with glob")
 "infra construction")
 "Tata")
 "India, US, Prime minister Modi, US President Joe Biden")
